These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Automated Algorithm for J-Tpeak and Tpeak-Tend Assessment of Drug-Induced Proarrhythmia Risk. Johannesen L; Vicente J; Hosseini M; Strauss DG PLoS One; 2016; 11(12):e0166925. PubMed ID: 28036330 [TBL] [Abstract][Full Text] [Related]
9. [Variants of arrhythmogenic action of anti-arrhythmia agents identified during choice of therapy by a transesophageal electrophysiological study]. Rychkov AIu; Shurin MS; Shakhov GG Kardiologiia; 1993; 33(1):87-9. PubMed ID: 8035557 [No Abstract] [Full Text] [Related]
10. [Arrhythmogenic effect of anti-arrhythmia drugs]. Trusz-Gluza M Kardiol Pol; 1991; 34(1):41-8. PubMed ID: 2051713 [No Abstract] [Full Text] [Related]
11. Digitalis-induced arrhythmias: recognition and management. Rios JC; Dziok CA; Ali NA Cardiovasc Clin; 1970; 2(2):261-79. PubMed ID: 4131127 [No Abstract] [Full Text] [Related]
12. [Arrhythmogenic effect of anti-arrhythmia drugs: incidence, possible mechanisms and therapeutic tactics]. Abdalla A; Mazur NA; Shestakova NV; Sumarokov AB Kardiologiia; 1990 Jan; 30(1):95-100. PubMed ID: 2186189 [No Abstract] [Full Text] [Related]
13. Astemizole-induced cardiac conduction disturbances in a child. Tobin JR; Doyle TP; Ackerman AD; Brenner JI JAMA; 1991 Nov; 266(19):2737-40. PubMed ID: 1942426 [TBL] [Abstract][Full Text] [Related]
14. Elevation of QT dispersion after obesity drug sibutramine. Yalcin AA; Yavuz B; Ertugrul DT; Algul B; Yilmaz H; Deveci OS; Kucukazman M; Ata N; Demirel G; Dal K; Tutal E J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):832-5. PubMed ID: 20671571 [TBL] [Abstract][Full Text] [Related]
15. Regulatory advice on evaluation of the proarrhythmic potential of drugs. Stockbridge N; Throckmorton DC J Electrocardiol; 2004; 37 Suppl():40-1. PubMed ID: 15534791 [No Abstract] [Full Text] [Related]